Zepbound 5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FZ0Y3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,486
Award facts
- Contract value 100% obligated
- $17,485.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,485.90 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pens on January 23, 2026. The contract utilizes firm fixed-price pricing with no set-aside designation, indicating the award was made through full and open competition. Performance will be completed at the awardee's facility in Conshohocken, Pennsylvania, with an ultimate completion date of January 26, 2026. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal medical procurement needs for military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The IDC enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, encompassing specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities across multiple therapeutic domains. This particular task order for Zepbound, a diabetes treatment medication, exemplifies the company's role in fulfilling essential pharmaceutical requirements for Defense Health Agency operations and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FZ0Y3?
SPE2DR26FZ0Y3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 23, 2026.
How much is contract SPE2DR26FZ0Y3 worth?
The government has obligated $17,486 on SPE2DR26FZ0Y3.
Is contract SPE2DR26FZ0Y3 an order under another contract?
Yes. SPE2DR26FZ0Y3 is a delivery order under SPE2DR25D2018, an indefinite delivery contract.
Was contract SPE2DR26FZ0Y3 competed?
The extent of competition for SPE2DR26FZ0Y3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award